Achieving an ideal work-life balance is the toughest challenge faced by medical residents, according to a Medscape survey featuring responses from more than 1,900 residents.
The FDA on Aug. 17 sent a letter warning cardiologists about high mortality and stroke rates associated with the Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System during a post-approval study.
Patients with valvular heart disease were significantly less likely to receive transthoracic echocardiograms (TTEs) within guideline-recommended timeframes if they were women, black, older or used Medicaid insurance, according to a single-center study published in JACC: Cardiovascular Imaging.
A study published in Pediatrics suggests adolescent muscle weakness measured by grip strength is a predictor of unhealthy outcomes, including cardiovascular and metabolic diseases.
New research published in the Journal of the American Medical Association suggests stroke patients receive better care at teaching hospitals and have reduced rates of readmission during the early stages of their recovery.
New York University School of Medicine will cover tuition expenses for all new and current medical students, according to an Aug. 16 university release. The scholarship initiative, the first such program at a top-10 medical school, will cover $55,000 in costs for all students in the MD program.
Transcatheter aortic valve replacement (TAVR) has provided relief to thousands of Americans who suffer from leaky heart valves and are too frail to undergo open-heart surgery. But policy and business considerations behind TAVR has large and small hospitals fighting over who will perform the procedures.
New research published in The Lancet Neurology suggests four factors can help physicians predict whether intracerebral hemorrhage (ICH) patients are likely to experience further bleeding.
Patients with type 2 diabetes (T2D), who met target ranges for five particular cardiovascular risk factors, appeared to have little or no excess risk of death, myocardial infarction (MI) or stroke, according to a new study published Aug. 16 in the New England Journal of Medicine.
People with essential fructosuria, a rare genetic mutation, don’t have the enzyme needed to metabolize fructose, found in honey, fruits and vegetables. The benefit? Little to no risk of developing obesity or type 2 diabetes, reports Bloomberg.
